複雑な尿路感染症における静脈内用フォスフォマイシン
Zachary J Nuss1, Sydney Berthold2
1Infectious Disease Consultants, Wichita, KS, USA.
The Annals of pharmacotherapy
|February 19, 2026
まとめ
静脈内用フォスフォマイシンは,合併症性尿路感染症 (CUTIs) に対して有望であり,いくつかの試験で非劣等性を実証しています. しかし,多剤耐性バクテレミアにおける非劣劣性を満たせず,他の試験ではより有害な効果を示した.
科学分野:
- 薬理学と感染症
- 抗菌薬の管理について
- 臨床試験分析 臨床試験分析について
背景:
- 合併症性尿路感染症 (CUTIs) は,抗菌剤耐性が増加しているため,大きな課題となっています.
- 新しい治療法の開発は,CUTIsの効果的な管理に不可欠です.
- 静脈内 (IV) フォスフォマイシンは,近年,CUTIsの治療にFDAの承認を受けています.
研究 の 目的:
- 合併症性尿路感染症 (CUTIs) に対して,FDAが新たに承認した静脈内 (IV) フォスフォマイシンの治療的役割を評価する.
- IVフォスフォマイシンの有効性および安全性を,CUTIsの既存の治療法と比較して評価する.
主な方法:
- ClinicalTrials.govとPubMedのデータベースを体系的に検索する.
- CUTIsにおけるIVフォスフォマイシンに関する2つの主要な第3相ランダム化対照試験 (RCT) の特定と分析.
- 比較分析のための補助研究と臨床実務ガイドラインの含有.
主要な成果:
- ZEUS試験は,拡張スペクトルベータラクタマース (ESBL) サブグループを含むCUTI/急性ピエロネフライト (AP) に対して,IVフォスフォミシンがピペラシリンタゾバクタム (PIP-TAZ) よりも劣らぬ効果を示した.
- FOREST試験では,IVフォスフォマイシンは,尿源の多剤耐性 (MDR) バクテリアミアにおいて,セフトリアクソンまたはメロペネムに対する非劣等性を満たしていないことが判明しました.
- IVフォスフォマイシンは,カルバペネムとフルオロキノロンを節約する選択肢であり,安定した患者のESBLを生成する非細菌性CUTI/APには特に効果的です.
結論:
- 静脈内用フォスフォマイシンは,薬剤耐性CUTIsと戦う可能性のある米国における新しい抗生物質製剤です.
- それは,特に特定の患者集団と耐性病原体に対して,代替治療戦略を提供します.
関連する概念動画
01:17Urinary Tract Infection IV: Nursing Management
517
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
517
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
348
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
348
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
486
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
486
01:30Urinary Tract Calculi III: Medical Management
290
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
290
01:27Acute Pyelonephritis I: Introduction
792
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
792
01:28Urinary Tract Calculi V: Nursing Management
348
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
348